Sangamo Therapeutics, Inc. SGMOQ

0.14 (0.01) (6.67%) as of 25 Sep
Market cap
$41.9M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Mar '26 Dec '25 Sep '25 Jun '25 Older periods
Cash and Short Term Investments
27.59 20.95 30.53 38.34

+8 more quarters

Receivables
0.87 0.37 0.52 0.37
Other current assets
5.49 10.14 4.60 4.60
Total current assets
37.11 35.83 44.08 49.89
Property, Plant, Equpment (Net)
10.32 11.04 14.79 15.73
Long-term assets (Other)
9.63 9.81 15.35 16.87
Total non-current assets
22.85 23.92 44.57 47.67
Total Assets
59.97 59.75 88.64 97.56
Accounts Payable
19.31 14.44 15.56 10.74
Accrued Expenses
18.34 17.72 17.15 15.43
Current Revenue (Deferred)
0.40 0.90 7.56 7.56
Total current liabilities
53.13 42.47 50.13 47.66
Non-current Revenue (Deferred)
5.87 5.87 5.87 5.87
Non-current Liabilities (Other)
0.58 0.58 0.98 0.96
Total non-current liabilities
25.79 31.55 32.28 30.30
Total liabilities
78.92 74.01 82.40 77.96
Additional Paid In Capital
1,637.66 1,610.94 1,594.30 1,573.23
Common Stock (Net)
4.14 3.51 3.22 2.73
Retained Earnings
(1,658.24) (1,627.25) (1,589.83) (1,554.90)
Common Equity (Total)
(18.95) (14.27) 6.24 19.60
Shareholders Equity (Total)
(18.95) (14.27) 6.24 19.60
Shareholders Equity and Liabilities (Total)
59.97 59.75 88.64 97.56
Shares (Common)
414.27 350.69 322.01 272.80
Shareholders Equity (Tangible)
(18.95) (14.27) 6.24 19.60
Net Debt
(27.59) (20.95) (30.53) (38.34)

Fold the line items

In millions of $ except per-share values · columns are period end dates